ENDOZYME^® II GO

ENDOTOXIN TESTING MADE FASTER, EASIER, AND SUSTAINABLE

Decrease handling time to improve workflow efficiency, and enable faster, easier and more consistent endotoxin testing.

By significantly reducing hands-on time, ENDOZYME^® II GO not only makes your lab more efficient — it reduces the risk of invalid results and reduces laboratory waste by eliminating manual preparation steps that are prone to handling errors.

Request Information

Image 1

Overview
Portfolio
Resources

Thanks to its 96-well pre-filled GOPLATE™, the ENDOZYME^® II GO recombinant factor C (rFC) endotoxin detection assay eliminates the need for any vortexing, mixing, diluting, or adding of Control Standard Endotoxin (CSE) to achieve the standard curve and PPC’s.

Benefits

Hands-on time reduced by over 50% for a streamlined workflow
Lot-to-lot reproducibility with Recombinant Scientific Characterization
Optimized testing costs with fewer invalid results
No false positives
Easy automation
Sustainable, using recombinant Factor C technology
Reliable results from in-process control to final product testing
Allows for high throughput

Features

96-well pre-filled GOPLATE™ with positive product controls
Single recombinant protein with small fluorescent peptide
rFC-based assay with no Factor G pathway

ENDOZYME^® II GO Portfolio

ENDOZYME II GO single kits
ENDOZYME II GO bulk kits
ENDOZYME II GO Strips
ENDOZYME Software

Resources

BROCHURE - ENDOZYME^® II GO

DOWNLOAD

Filename: PHARMA_BROCHURE_EZIIGO.pdf
Size: 574 KB
Format: application/pdf

CITATION LIST - Recombinant Factor C (rFC) Assay

DOWNLOAD

Filename: BMX_rFC_Citation_List_2022.pdf
Size: 74 KB
Format: application/pdf

Revolutionize Your Endotoxin Testing

Embark on a 6-part journey designed to challenge the traditional norms in endotoxin detection.

The Hunt for the Missing Endotoxin

This white paper reviews the causes contributing to low endotoxin recovery (LER), the impact it creates, as well as solutions which can rectify the issues it results in. We also discuss the advantages and disadvantages of developing your de-masking protocols in-house, and how you can use the ENDO-RS® de-masking tool kit to make the process easier from beginning to end. Following this, we outline the pros and cons of outsourcing your de-masking project, what you should look for in a third-party company, and why you can and should trust bioMérieux with your de-masking protocol development.

WHITE PAPER

Adoption of rFC for bacterial endotoxin testing

With industry’s push to build a more diverse global supply chain, we find ourselves at a tipping point for the widespread adoption of alternative solutions like rFC — driven as much by industry, if not more, than regulators.

WHITEPAPER

Low Endotoxin Recovery case studies

This case study discusses the Low Endotoxin Recovery (LER) phenomenon in the drug testing and mitigation approach using the ENDO-RS® kit and ENDOLISA® assay for detecting endotoxin interference.

WHITEPAPER

Waste in Endotoxin Detection Assays LAL vs rFC

From traditional to alternate endotoxin testing methods used for product release testing, there is an opportunity to waste less reagent and generate cost savings.

The Hunt for the Missing Endotoxin
The Hunt for the Missing Endotoxin
Adoption of rFC for bacterial endotoxin testing
Low Endotoxin Recovery case studies
Waste in Endotoxin Detection Assays LAL vs rFC

Explore All Endotoxin Solutions

ENDOXPERTS^™Services

ENDOXPERTS™ Endotoxin Services by bioMérieux provide routine testing and feasibility studies as well as specialized services for analytical issues such as LER. Our work for leading pharmaceutical companies has resulted in validated methods for LER, fulfilling regulatory requirements.

Learn More

ENDOZYME^® II GO STRIPS

Laboratories don’t always need to test all 20 samples to fill a full plate—that’s why ENDOZYME® II GO STRIPS are designed with flexibility in mind: the flexibility to use only what you need, when you need it.

Learn More